72 related articles for article (PubMed ID: 3723170)
1. Circulating antigen levels in ovarian cancer.
Colomer R; Genollà J; del Campo JM; Ruibal A
J Clin Oncol; 1986 Jul; 4(7):1148-9. PubMed ID: 3723170
[No Abstract] [Full Text] [Related]
2. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.
Sekine H; Hayes DF; Ohno T; Keefe KA; Schaetzl E; Bast RC; Knapp R; Kufe DW
J Clin Oncol; 1985 Oct; 3(10):1355-63. PubMed ID: 2413181
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the serum levels of a carbohydrate antigen 19-9 (CA 19-9) in patients with ovarian cancer].
Miyoshi T; Nishimura H; Ookura N; Morisaki H; Kobayashi H; Tasaki T; Ushijima H; Yakushiji M
Igaku Kenkyu; 1984 Dec; 54(8):796-800. PubMed ID: 6599577
[No Abstract] [Full Text] [Related]
4. [Reverse hemagglutination (RHA) test for detection of ovarian cancer antigen in serum].
Liu WS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Aug; 10(4):308-9. PubMed ID: 2976323
[No Abstract] [Full Text] [Related]
5. Tumor marker in ovarian cancer. Tumor-associated antigen.
Barlow JJ; Bhattacharya M
N Y State J Med; 1977 Mar; 77(3):342-3. PubMed ID: 265013
[No Abstract] [Full Text] [Related]
6. [Ovarian metastatic antigen in the blood serum of patients with ovarian tumors].
Borisenko SA; Makarov OV; Petrushina VA; Prokopenko PG
Akush Ginekol (Mosk); 1990 Jun; (6):42-4. PubMed ID: 2221264
[TBL] [Abstract][Full Text] [Related]
7. Detection of malignant ovarian neoplasms: a review of the literature. III. Immunological detection and ovarian cancer-associated antigens.
Smith LH; Oi RH
Obstet Gynecol Surv; 1984 Jun; 39(6):346-60. PubMed ID: 6203071
[TBL] [Abstract][Full Text] [Related]
8. [Clinical usefulness of serum TPA, IAP and CEA levels in gynecological cancer].
Saitoh S; Nakanishi A; Noda T; Ando Y; Kamamoto Y; Moriyama I; Ichijo M
Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1496-504. PubMed ID: 6520506
[No Abstract] [Full Text] [Related]
9. [Human ovarian cancer antigen assayed by an active rosette formation test for immunodiagnosis].
Gong Y
Zhonghua Fu Chan Ke Za Zhi; 1983 Jul; 18(3):164-6. PubMed ID: 6653198
[No Abstract] [Full Text] [Related]
10. [Serum levels of the CA-125 antigen in the diagnosis of ovarian neoplasms].
Sopracordevole F; Finco B; Scarabelli C; Campagnutta E; Alimena C; Perin A
Minerva Ginecol; 1985 Oct; 37(10):589-96. PubMed ID: 3866146
[No Abstract] [Full Text] [Related]
11. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
Crombach G; Zippel HH; Würz H
Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
[TBL] [Abstract][Full Text] [Related]
12. [Detection of CA-125 antigen (non-mucinous ovarian cancer antigen)-- in serum of patients with gynecological malignancies].
Sakamoto S; Kawana H; Shimizu K; Ishihara T; Ueda K; Usman SM; Uchida S; Kawagoe K; Kihara K; Kubo H
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug; 36(8):1261-2. PubMed ID: 6595322
[No Abstract] [Full Text] [Related]
13. Tumor antigens in ovarian malignancy.
Rubin SC; Lewis JL
Clin Obstet Gynecol; 1986 Sep; 29(3):693-704. PubMed ID: 2428553
[No Abstract] [Full Text] [Related]
14. [Immunoenzyme study of interspecific embryonic antigens in the blood serum of ovarian cancer patients].
Chekhonin VP; Makarov OV; Tatarinov IuS; Griaznova IM
Akush Ginekol (Mosk); 1987 Mar; (3):69-70. PubMed ID: 3296812
[No Abstract] [Full Text] [Related]
15. Tumour markers in ovarian cancer.
van Nagell JR
Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919
[No Abstract] [Full Text] [Related]
16. [Ovarian carcinoma-associated antigen isolated from peritoneal effusions in clinical diagnosis].
Qian HN
Zhonghua Fu Chan Ke Za Zhi; 1983 Oct; 18(4):242-6. PubMed ID: 6426896
[No Abstract] [Full Text] [Related]
17. Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.
Yuan CC; Ng HT; Tsai LC; Jeng FS; Yeh SH; Tsai YC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):190-7. PubMed ID: 3480793
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of the tumor marker CA125 in ovarian tumor (a cooperative study among 8 institutions)].
Kato T; Nishimura H; Hamai J; Yamabe T; Nakajima H; Nakano T; Noda K; Teshima K; Suzuki H; Ueda G
Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2338-45. PubMed ID: 3007640
[No Abstract] [Full Text] [Related]
19. CA 125 and TPA as markers in ovarian carcinoma.
Rodenburg CJ; De Maaker GA; Trimbos JB; Moolenaar AJ; Van Oosterom AT
Neth J Med; 1985; 28(12):536-40. PubMed ID: 2418375
[No Abstract] [Full Text] [Related]
20. [Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors].
Tohya T; Inoue S; Tanaka N; Fujisaki S; Maeyama M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2872-5. PubMed ID: 3910744
[No Abstract] [Full Text] [Related]
[Next] [New Search]
